Key facts
- Status: Acquired/Merged (Operating Subsidiary).
- ·Watchlist + deal alerts for Veda Trials
- ·The full record, as it builds
Funding rounds
No funding rounds for Veda Trials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Veda Trials
Provider of clinical trial management services intended to accelerate the speed and scale of clinical research. The company offers tools and resources to connect healthcare organizations with patients for clinical trials along with site activation and community-based trial operations, enabling biopharma companies to expand research access.
- Sector
- Healthcare
- HQ
- Frederick, MD, United States
- Founded
- 2023
- Employees
- 9
- Website
- vedatrials.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Veda Trials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Veda Trials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Veda Trials in its N-PORT filings yet. We sweep new filings monthly.